These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33037313)

  • 1. The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice.
    Rangrez AY; Borlepawar A; Schmiedel N; Deshpande A; Remes A; Kumari M; Bernt A; Christen L; Helbig A; Jungmann A; Sossalla S; Tholey A; Müller OJ; Frank D; Frey N
    Commun Biol; 2020 Oct; 3(1):562. PubMed ID: 33037313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.
    Bernt A; Rangrez AY; Eden M; Jungmann A; Katz S; Rohr C; Müller OJ; Katus HA; Sossalla ST; Williams T; Ritter O; Frank D; Frey N
    Sci Rep; 2016 Oct; 6():35758. PubMed ID: 27767176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
    Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
    Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway.
    Goto J; Otaki Y; Watanabe T; Kobayashi Y; Aono T; Watanabe K; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Shishido T; Watanabe M
    Hypertension; 2020 Dec; 76(6):1868-1878. PubMed ID: 33131309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
    Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
    J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between syntaxin 8 and HECTd3, a HECT domain ligase.
    Zhang L; Kang L; Bond W; Zhang N
    Cell Mol Neurobiol; 2009 Feb; 29(1):115-21. PubMed ID: 18821010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite motif 32 prevents pathological cardiac hypertrophy.
    Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
    Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
    Liu H; Zhou Z; Deng H; Tian Z; Wu Z; Liu X; Ren Z; Jiang Z
    Eur J Pharmacol; 2023 Jun; 949():175735. PubMed ID: 37080331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF13 protects against pathological cardiac hypertrophy through p62-NRF2 pathway.
    Guo S; Zhang BB; Gao L; Yu XY; Shen JH; Yang F; Zhang WC; Jin YG; Li G; Wang YG; Han ZY; Liu Y
    Free Radic Biol Med; 2023 Nov; 209(Pt 2):252-264. PubMed ID: 37852547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara.
    Yu J; Lan J; Zhu Y; Li X; Lai X; Xue Y; Jin C; Huang H
    Biochem Biophys Res Commun; 2008 Mar; 367(4):805-12. PubMed ID: 18194665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis.
    Zeng G; Lian C; Yang P; Zheng M; Ren H; Wang H
    Aging (Albany NY); 2019 Jun; 11(11):3536-3550. PubMed ID: 31171760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
    Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
    Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
    Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH
    Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.